ArticleThe Journal of clinical investigation2025

Dual targeting of CDK4/6 and CDK7 augments tumor response and antitumor immunity in breast cancer models.

Sungsoo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.